Limited Time Offer. Become a Founder Member Now!

Industry and labs back bill to make WSDA sole accreditor for cannabis testing labs

March 31, 2025 | Labor & Commerce, Senate, Legislative Sessions, Washington


This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »

Industry and labs back bill to make WSDA sole accreditor for cannabis testing labs
House Bill 13 47, which passed the House earlier this session, would require the Liquor and Cannabis Board (LCB) to accept accreditation of cannabis testing laboratories by the Washington State Department of Agriculture (WSDA) as the sole basis for certifying or renewing lab certification, provided the lab has not violated specified LCB requirements.

Caitlin Ryan of the Cannabis Alliance testified in support and asked for clarifying amendments that would define LCB’s authority narrowly to oversight of required quality-assurance testing, financial conflicts, and transport/possession protocols. She requested that non-mandatory or research-and-development test results not be required to be reported into the state traceability system.

Brooke Davies of the Washington Cannabis Business Association told the committee labs are now regulated by multiple agencies (Department of Health, LCB and WSDA) and said the bill seeks statutory clarity to reduce redundancies and conflicts in agency rules. Nick Mosley, who works for a WSDA-accredited testing lab, said the statute would align with prior legislative decisions to move lab accreditation to WSDA (citing the legislature’s prior work beginning with House Bill 2052) and recommended clarifying amendments to reflect that intent.

Committee staff reported the bill passed the House 95–2 and staff recommended the change to reduce duplicative agency oversight. Witnesses asked the committee to add language clarifying that LCB’s authority is limited to oversight of required testing and certain chain-of-custody responsibilities, rather than method validation or other lab-accreditation functions.

No final committee action on HB 13 47 is recorded in the transcript excerpt beyond the testimony; committee staff invited written technical amendments.

View full meeting

This article is based on a recent meeting—watch the full video and explore the complete transcript for deeper insights into the discussion.

View full meeting

Sponsors

Proudly supported by sponsors who keep Washington articles free in 2025

Scribe from Workplace AI
Scribe from Workplace AI